Therapeutic Asset Ratings
184 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Carboplatin
Triple Negative Breast Cancer
M.D. Anderson Cancer Center
P4
BB
(70)
Cyclophosphamide
Triple Negative Breast Cancer
M.D. Anderson Cancer Center
P4
BB
(70)
Atezolizumab
Triple Negative Breast Cancer
European Institute of Oncology
P3
BB
(68)
Epirubicin
Triple Negative Breast Cancer
M.D. Anderson Cancer Center
P4
BB
(67)
CIS-DIAMMINEDICHLOROPLATINUM II
Triple Negative Breast Cancer
Andrew Hantel, MD
P3
BB
(66)
Inno-206
Triple Negative Breast Cancer
Yuan Yuan
P3
BB
(66)
Pembrolizumab
Triple Negative Breast Cancer
M.D. Anderson Cancer Center
P3
BB
(66)
Capecitabine
Triple Negative Breast Cancer
National University Hospital, Singapore
P3
BB
(64)
Eloxatin
Triple Negative Breast Cancer
Pfizer
P3
BB
(64)
FILGRASTIM
Triple Negative Breast Cancer
MedSIR
P3
BB
(64)
Toripalimab
Triple Negative Breast Cancer
Nanjing Leads Biolabs Co.,Ltd
P3
BB
(64)
Vinorelbine
Triple Negative Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
P3
BB
(64)
ERIBULIN MONOMETHANESULFONATE
Triple Negative Breast Cancer
National Cancer Institute (NCI)
P3
B
(63)
FLUOROURACILUM
Triple Negative Breast Cancer
Pfizer
P3
B
(63)
Pyrotinib
Triple Negative Breast Cancer
Fudan University
P3
B
(63)
Rivoceranib
Triple Negative Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P3
B
(63)
(+)-VINCRISTINE
Triple Negative Breast Cancer
Fudan University
P2
B
(63)
Docetaxel
Triple Negative Breast Cancer
BioLite, Inc.
P3
B
(62)
Olaparib
Triple Negative Breast Cancer
AHS Cancer Control Alberta
P3
B
(62)
Calcium folinate pentahydrate
Triple Negative Breast Cancer
Pfizer
P3
B
(61)
PEGFILGRASTIM
Triple Negative Breast Cancer
Yonsei University
P3
B
(61)
Durvalumab
Triple Negative Breast Cancer
Queen Mary University of London
P2
B
(61)
Adebrelimab
Triple Negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P3
B
(60)
Benmelstobart
Triple Negative Breast Cancer
Fudan University
P3
B
(60)
Catequentinib
Triple Negative Breast Cancer
Jiangsu Cancer Institute & Hospital
P3
B
(60)
Showing 1 to 25 of 184 assets
Previous
Page 1 of 8
Next